Roman DBDR Acqsn Financials
This page shows Roman DBDR Acqsn (DRDB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Roman DBDR Acqsn's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Roman DBDR Acqsn's current ratio of 0.35 is below the typical benchmark, resulting in a score of 1/100. This tight liquidity could limit financial flexibility if cash inflows slow.
For every $1 of reported earnings, Roman DBDR Acqsn generates $-0.17 in operating cash flow (-$1.3M OCF vs $7.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Roman DBDR Acqsn reported $7.7M in net income in fiscal year 2025.
Cash & Balance Sheet
Roman DBDR Acqsn held $183K in cash against $0 in long-term debt as of fiscal year 2025.
Margins & Returns
Capital Allocation
DRDB Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | $513K+30.0% | $395K+15.6% | $341K | N/A | $91K |
| Operating Income | N/A | -$513K-30.0% | -$395K-15.6% | -$341K | N/A | -$91K |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | $0 | N/A | $0 |
| Net Income | N/A | $2.1M+5.4% | $2.0M-8.4% | $2.2M | N/A | -$91K |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A |
DRDB Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|
| Total Assets | $241.5M+0.9% | $239.3M+1.0% | $237.0M+0.9% | $235.0M+15.9% | $202.8M+103155.0% | $196K |
| Current Assets | $318K-34.0% | $481K-39.2% | $791K-30.4% | $1.1M-18.8% | $1.4M+21140.6% | $7K |
| Cash & Equivalents | $183K-43.5% | $324K-47.7% | $619K-34.8% | $948K-25.4% | $1.3M | $0 |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $242.3M+1.3% | $239.1M+1.2% | $236.3M+1.0% | $233.8M+16.0% | $201.6M+70110.9% | $287K |
| Current Liabilities | $896K+225.1% | $276K+179.7% | $99K+31.3% | $75K-75.1% | $302K | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$778K-445.6% | $225K-69.5% | $738K-34.8% | $1.1M-5.2% | $1.2M+1417.4% | -$91K |
| Retained Earnings | -$779K-447.1% | $224K-69.6% | $738K-34.9% | $1.1M+406.8% | $223K+346.3% | -$91K |
DRDB Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -$341K-15.4% | -$295K+10.5% | -$330K-1.9% | -$323K | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $0 | $0 | $0+100.0% | -$30.1M | N/A | N/A |
| Financing Cash Flow | $200K | $0 | $0-100.0% | $30.1M | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A |
DRDB Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | 949.5%+674.9pp | 274.6%+79.2pp | 195.4% | N/A | N/A |
| Return on Assets | N/A | 0.9%+0.0pp | 0.9%-0.1pp | 0.9% | N/A | -46.2% |
| Current Ratio | 0.35-1.4 | 1.75-6.3 | 8.03-7.1 | 15.14+10.5 | 4.63 | N/A |
| Debt-to-Equity | -311.38-1373.4 | 1062.05+742.1 | 319.97+113.6 | 206.35+37.7 | 168.66+171.8 | -3.16 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$778K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.35), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
Is Roman DBDR Acqsn profitable?
Yes, Roman DBDR Acqsn (DRDB) reported a net income of $7.7M in fiscal year 2025.
What is Roman DBDR Acqsn's operating cash flow?
Roman DBDR Acqsn (DRDB) generated -$1.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Roman DBDR Acqsn's total assets?
Roman DBDR Acqsn (DRDB) had $241.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Roman DBDR Acqsn's current ratio?
Roman DBDR Acqsn (DRDB) had a current ratio of 0.35 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Roman DBDR Acqsn's debt-to-equity ratio?
Roman DBDR Acqsn (DRDB) had a debt-to-equity ratio of -311.38 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Roman DBDR Acqsn's return on assets (ROA)?
Roman DBDR Acqsn (DRDB) had a return on assets of 3.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Roman DBDR Acqsn's cash runway?
Based on fiscal year 2025 data, Roman DBDR Acqsn (DRDB) had $183K in cash against an annual operating cash burn of $1.3M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Roman DBDR Acqsn's debt-to-equity ratio negative or unusual?
Roman DBDR Acqsn (DRDB) has negative shareholder equity of -$778K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Are Roman DBDR Acqsn's earnings high quality?
Roman DBDR Acqsn (DRDB) has an earnings quality ratio of -0.17x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Roman DBDR Acqsn?
Roman DBDR Acqsn (DRDB) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.